Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea

Alcaide, 1997, Molecular techniques in the diagnosis of drug-resistant tuberculosis, Ann. Acad. Med. Singap., 26, 647 Chan, 2001, Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype, Epidemiol. Infect., 127, 169, 10.1017/S0950268801005659 Drobniewski, 1998, The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis—a molecular story, J. Med. Microbiol., 47, 189, 10.1099/00222615-47-3-189 Drobniewski, 2002, Rifampin- and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the Beijing strain family, Emerg. Infect. Dis., 8, 1320, 10.3201/eid0811.020507 Espinal, 2001, Global trends in resistance to antituberculosis drugs, N. Engl. J. Med., 344, 1294, 10.1056/NEJM200104263441706 Heym, 1994, Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study, Lancet, 344, 293, 10.1016/S0140-6736(94)91338-2 Heym, 1997, Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis, Infect. Immun., 65, 1395, 10.1128/IAI.65.4.1395-1401.1997 Iseman, 1993, Treatment of multidrug-resistant tuberculosis, N. Engl. J. Med., 329, 784, 10.1056/NEJM199309093291108 Kamerbeek, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J. Clin. Microbiol., 35, 907, 10.1128/JCM.35.4.907-914.1997 Kiepiela, 2000, Genomic mutations in the katG, inhA and ahpC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal South Africa, Tuber. Lung Dis., 80, 47, 10.1054/tuld.1999.0231 Kim, 1997, Drug-resistant tuberculosis in Korea, 1994, Int. J. Tuberc. Lung Dis., 1, 302 Kox, 1995, PCR assay based on DNA coding for 16S rRNA for detection and identification of Mycobacteria in clinical samples, J. Clin. Microbiol., 33, 3225, 10.1128/JCM.33.12.3225-3233.1995 Krüüner, 2001, Spread of drug-resistant pulmonary tuberculosis in Estonia, J. Clin. Microbiol., 39, 3339, 10.1128/JCM.39.9.3339-3345.2001 Mokrousov, 2003, PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia, Eur. J. Clin. Microbiol. Infect. Dis., 22, 342, 10.1007/s10096-003-0944-0 Narvskaya, 2002, Nosocomial outbreak of multidrug-resistant tuberculosis caused by a strain of Mycobacterium tuberculosis W-Beijing family in St. Petersburg, Russia, J. Clin. Microbiol. Infect. Dis., 21, 596, 10.1007/s10096-002-0775-4 Park, 2000, Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the Western Pacific Region, J. Clin. Microbiol., 38, 191, 10.1128/JCM.38.1.191-197.2000 Pym, 2002, Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans, Infect. Immun., 70, 4955, 10.1128/IAI.70.9.4955-4960.2002 Qian, 2002, rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries, J. Clin. Microbiol., 40, 1091, 10.1128/JCM.40.3.1091-1094.2002 Ramaswamy, 1998, Melecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tuber. Lung Dis., 79, 3, 10.1054/tuld.1998.0002 Ramaswamy, 2003, Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis, Antimicrob. Agents Chemother., 47, 1241, 10.1128/AAC.47.4.1241-1250.2003 Sherman, 1996, Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis, Science, 272, 1641, 10.1126/science.272.5268.1641 Telenti, 1993, Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis, Lancet, 341, 647, 10.1016/0140-6736(93)90417-F Telzak, 1995, Multidrug-resistant tuberculosis in patients without HIV infection, N. Engl. J. Med., 333, 907, 10.1056/NEJM199510053331404 Torres, 2002, Rifampin and isoniazid resistance associated mutations in Mycobacterium tuberculosis clinical isolates in Seville, Spain, Int. J. Tuberc. Lung Dis., 6, 160 Toungoussova, 2002, Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia, J. Clin. Microbiol., 40, 1930, 10.1128/JCM.40.6.1930-1937.2002 van Soolingen, 1995, Predominance of single genotype of Mycobacterium tuberculosis in countries of East Asia, J. Clin. Microbiol., 33, 3234, 10.1128/JCM.33.12.3234-3238.1995 van Soolingen, 2000, Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands, J. Infect. Dis., 182, 1788, 10.1086/317598 Werngren, 2003, Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate, J. Clin. Microbiol., 41, 1520, 10.1128/JCM.41.4.1520-1524.2003 Williams, 1998, Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis, Antimicrob. Agents Chemother., 42, 1853, 10.1128/AAC.42.7.1853 World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2003. Geneva, Switzerland, WHO/CDS/TB2003.316.